1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SUN PHARMACEUTICAL INDUSTRIES LTD.

Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA | BSE: 524715

Sun Pharmaceutical Industries Ltd. Live Share Price Today, Share Analysis and Chart

Expensive Performer
Download real time

1683.45 6.60 (0.39%)

1.8M NSE+BSE Volume

NSE 13 Mar, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
85.0 / 100
Valuation Score
Expensive Valuation
26.5 / 100
Momentum Score
Technically Neutral
41.2 / 100
Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
2,056
1Yr Price target upside is 22%
37 analysts

18

S

3

W

7

O

1

T

SWOT Analysis

Sun Pharmaceutical Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

06 Feb, 2025 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link AI Summary
31 Jan, 2025 TRENDLYNE
Sun Pharmaceutical Industries Results Earnings Call for Q3FY25
Sun Pharmaceutical Industries Results Earnings Call for Q3FY25
video link
31 Jan, 2025 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Q3FY25 Investor Call Audio Record…
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Q3FY25 Investor Call Audio Record…
pdf link
04 Nov, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link AI Summary
28 Oct, 2024 TRENDLYNE
Sun Pharmaceutical Industries Results Earnings Call for Q2FY25
Sun Pharmaceutical Industries Results Earnings Call for Q2FY25
video link
28 Oct, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Q2FY25 Investor Call Audio Record…
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Q2FY25 Investor Call Audio Record…
pdf link
07 Aug, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link AI Summary
01 Aug, 2024 TRENDLYNE
Sun Pharmaceutical Industries Results Earnings Call for Q1FY25
Sun Pharmaceutical Industries Results Earnings Call for Q1FY25
audio video link
01 Aug, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Investor Call Audio Recording
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Investor Call Audio Recording
pdf link
29 May, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link AI Summary
22 May, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Investor Call Audio Recording
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Investor Call Audio Recording
pdf link
22 May, 2024 TRENDLYNE
Sun Pharmaceutical Industries Results Earnings Call for Q4FY24
Sun Pharmaceutical Industries Results Earnings Call for Q4FY24
audio video link
All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
06 Mar, 2025 ICRA RATINGS
Sun Pharmaceutical Industries Limited
Ratings reaffirmed
link
27 Dec, 2024 CRISIL RATINGS
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited:Ratings reaffirmed at 'CRISIL AAA/Stable/CRISIL A1+'
link
04 Mar, 2024 ICRA RATINGS
Sun Pharmaceutical Industries Limited
Ratings reaffirmed
link
25 Jan, 2024 CRISIL RATINGS
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited:Update on Sun Pharmaceutical Industries Limited
link
03 Jan, 2024 CRISIL RATINGS
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited:Ratings reaffirmed at 'CRISIL AAA/Stable/CRISIL A1+'
link
13 Apr, 2023 CRISIL RATINGS
Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited:Rating Withdrawn
link
16 Mar, 2023 CRISIL RATINGS
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited:Update on Sun Pharmaceutical Industries Limited
link
06 Mar, 2023 ICRA RATINGS
Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited: Rating reaffirmed; withdrawn for Commercial Paper Programme
link
06 Mar, 2023 ICRA RATINGS
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited: Ratings reaffirmed/assigned; withdrawn for Proposed Borrowing Programme
link
27 Jan, 2023 CRISIL RATINGS
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited:Ratings Reaffirmed
link
30 Aug, 2022 CRISIL RATINGS
Sun Pharma Laboratories Limited
Sun Pharma Laboratories Limited:Rating reaffirmed at 'CRISIL A1+'
link
06 Jun, 2022 CRISIL RATINGS
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited:Update on Sun Pharmaceutical Industries Limited
link
All Credit Ratings
04 Mar, 2025 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
28 Nov, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
30 Sep, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
10 Jul, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
14 Mar, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
04 Jan, 2024 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
11 Sep, 2023 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
21 Jul, 2023 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
28 Apr, 2023 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
16 Jan, 2023 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
16 Sep, 2022 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link
24 Mar, 2022 BSE INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 …
pdf link

Sun Pharmaceutical Industries Ltd. FAQ

How is Sun Pharmaceutical Industries Ltd. today?
Sun Pharmaceutical Industries Ltd. today is trading in the green, and is up by 0.39% at 1683.45.
Sun Pharmaceutical Industries Ltd. is currently trading up 0.39% on an intraday basis. In the past week the stock rose 4.30%. stock has been down -7.17% in the past quarter and rose 8.01% in the past year. You can view this in the overview section.